Skip to Main Content

Author Details

Mehdi Bouhaddou
J. David Gladstone Institutes
2014
42
20
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36692000Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms.Elife2023
37758692Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.Nat Commun2023
37738983Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.Cell Host Microbe2023
37738970SARS-CoV-2 variants evolve convergent strategies to remodel the host response.Cell2023
37938000Hepatitis C virus infects and perturbs liver stem cells.mBio2023
37291385Defining blood-induced microglia functions in neurodegeneration through multiomic profiling.Nat Immunol2023
37213254Current proteomics methods applicable to dissecting the DNA damage response.NAR Cancer2023
37204043Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer.Mol Omics2023
35332335Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.Nature2022
35729113A scalable, open-source implementation of a large-scale mechanistic model for single cell proliferation and death signaling.Nat Commun2022
35365639A functional map of HIV-host interactions in primary human T cells.Nat Commun2022
36549272How can systems approaches help us understand and treat infectious disease?Cell Syst2022
36316338Network inference from perturbation time course data.NPJ Syst Biol Appl2022
35189161Leveraging modeling and simulation to optimize the therapeutic window for epigenetic modifier drugs.Pharmacol Ther2022
35012962Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.Life Sci Alliance2022
34942634Evolution of enhanced innate immune evasion by SARS-CoV-2.Nature2022
35150638Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.Cell Host Microbe2022
33333024Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses.Cell2021
33495306Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.Science2021
34591612A protein interaction landscape of breast cancer.Science2021
34546978Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer.JCI Insight2021
34591642A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity.Science2021
34075384Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.medRxiv2021
34127972Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant.bioRxiv2021
34013269CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.bioRxiv2021
34031651CryoEM and AI reveal a structure of SARS-CoV-2 Nsp2, a multifunctional protein involved in key host processes.Res Sq2021
32353859A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.Nature2020
31729169Predicting In Vivo Efficacy from In Vitro Data: Quantitative Systems Pharmacology Modeling for an Epigenetic Modifier Drug in Cancer.Clin Transl Sci2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
32995787Functional genomic screens identify human host factors for SARS-CoV-2 and common cold coronaviruses.bioRxiv2020
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
32444466The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2.Cancer Discov2020
31288129Mapping the protein-protein and genetic interactions of cancer to guide precision medicine.Curr Opin Genet Dev2019
28950062Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.ACS Chem Neurosci2018
30054510Validating Antibodies for Quantitative Western Blot Measurements with Microwestern Array.Sci Rep2018
30339749Fluorescence Multiplexing with Spectral Imaging and Combinatorics.ACS Comb Sci2018
29579036A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens.PLoS Comput Biol2018
29342193Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.PLoS One2018
29116112A Comparison of mRNA Sequencing with Random Primed and 3'-Directed Libraries.Sci Rep2017
27905419Drug response consistency in CCLE and CGP.Nature2016
26549455Engineered Mammalian RNAi Can Elicit Antiviral Protection that Negates the Requirement for the Interferon Response.Cell Rep2015
24736836Dimerization-based control of cooperativity.Mol Biosyst2014
  • 1 - 42 of 42

Recommended Authors

Fred Hutchinson Cancer Research Center, USA Clinical Research Division
Career Start Year 2015
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network, University Ave.
Career Start Year 2013
Number of shared co-authors 0
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center, USA Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Ontario Institute for Cancer Research
Career Start Year 2008
Number of shared co-authors 0
Institute of Cancer and Genomic Sciences, University of Birmingham
Career Start Year 2008
Number of shared co-authors 1
University of Laval
Career Start Year 2007
Number of shared co-authors 1
University of Washington
Career Start Year 2007
Number of shared co-authors 0
Institute for Systems Biology
Career Start Year 2007
Number of shared co-authors 1
College of Medicine, Hanyang University
Career Start Year 2006
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 5
Pacific Northwest National Laboratory (PNNL)
Career Start Year 2006
Number of shared co-authors 0
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 2005
Number of shared co-authors 1
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 4
University of California San Francisco
Career Start Year 2004
Number of shared co-authors 28
Universite Cote d'Azur, CNRS UMR5
Career Start Year 2004
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2004
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 23
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 5
Pacific Northwest National Laboratory (PNNL)
Career Start Year 2002
Number of shared co-authors 0
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 8
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 5
Institute for Molecular Medicine Finland (FIMM), University of Helsinki
Career Start Year 1999
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 4
Berlin Institute of Health (BIH) and Charite
Career Start Year 1995
Number of shared co-authors 9
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 3
Institute for Systems Biology
Career Start Year 1993
Number of shared co-authors 1
Columbia University
Career Start Year 1993
Number of shared co-authors 9
Broad Institute of Harvard and MIT
Career Start Year 1993
Number of shared co-authors 7

Collaborators

University of California San Francisco
Co-authored papers 30
J. David Gladstone Institutes
Co-authored papers 15
J. David Gladstone Institutes
Co-authored papers 12
Clemson University.
Co-authored papers 12
University of California San Francisco
Co-authored papers 11
Icahn School of Medicine at Mount Sinai
Co-authored papers 11
J. David Gladstone Institutes
Co-authored papers 11
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 10
J. David Gladstone Institutes
Co-authored papers 10
University of California San Francisco
Co-authored papers 8
Cardiovascular Research Institute, University of California San Francisco
Co-authored papers 8
University of California, University of California San Francisco
Co-authored papers 8
Fred Hutchinson Cancer Center
Co-authored papers 7
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 7
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 7
J. David Gladstone Institutes
Co-authored papers 7
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
University of California San Francisco
Co-authored papers 6
Gladstone Institute of Virology
Co-authored papers 6
University College London
Co-authored papers 6
University of California san francisco
Co-authored papers 6
University of California, San Francisco
Co-authored papers 6
J. David Gladstone Institutes
Co-authored papers 6
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
University of Ottawa
Co-authored papers 6
University College London
Co-authored papers 6
European Bioinformatics Institute
Co-authored papers 6
University College London
Co-authored papers 5
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 5
University of California san francisco
Co-authored papers 5